• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KM-IPD: 从已发表的 Kaplan-Meier 生存曲线中重建个体患者数据。

IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves.

机构信息

Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, United States.

出版信息

BMC Med Res Methodol. 2021 Jun 1;21(1):111. doi: 10.1186/s12874-021-01308-8.

DOI:10.1186/s12874-021-01308-8
PMID:34074267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8168323/
Abstract

BACKGROUND

When applying secondary analysis on published survival data, it is critical to obtain each patient's raw data, because the individual patient data (IPD) approach has been considered as the gold standard of data analysis. However, researchers often lack access to IPD. We aim to propose a straightforward and robust approach to obtain IPD from published survival curves with a user-friendly software platform.

RESULTS

Improving upon existing methods, we propose an easy-to-use, two-stage approach to reconstruct IPD from published Kaplan-Meier (K-M) curves. Stage 1 extracts raw data coordinates and Stage 2 reconstructs IPD using the proposed method. To facilitate the use of the proposed method, we developed the R package IPDfromKM and an accompanying web-based Shiny application. Both the R package and Shiny application have an "all-in-one" feature such that users can use them to extract raw data coordinates from published K-M curves, reconstruct IPD from the extracted data coordinates, visualize the reconstructed IPD, assess the accuracy of the reconstruction, and perform secondary analysis on the basis of the reconstructed IPD. We illustrate the use of the R package and the Shiny application with K-M curves from published studies. Extensive simulations and real-world data applications demonstrate that the proposed method has high accuracy and great reliability in estimating the number of events, number of patients at risk, survival probabilities, median survival times, and hazard ratios.

CONCLUSIONS

IPDfromKM has great flexibility and accuracy to reconstruct IPD from published K-M curves with different shapes. We believe that the R package and the Shiny application will greatly facilitate the potential use of quality IPD and advance the use of secondary data to facilitate informed decision making in medical research.

摘要

背景

在应用已发表的生存数据进行二次分析时,获取每个患者的原始数据至关重要,因为个体患者数据(IPD)方法被认为是数据分析的金标准。然而,研究人员通常无法获得 IPD。我们旨在提出一种简单而稳健的方法,使用用户友好的软件平台从已发表的生存曲线中获取 IPD。

结果

在现有方法的基础上,我们提出了一种从已发表的 Kaplan-Meier(K-M)曲线中重建 IPD 的简单易用的两阶段方法。第 1 阶段提取原始数据坐标,第 2 阶段使用提出的方法重建 IPD。为了便于使用所提出的方法,我们开发了 R 包 IPDfromKM 和一个配套的基于 Shiny 的应用程序。R 包和 Shiny 应用程序都具有“一体化”功能,用户可以使用它们从已发表的 K-M 曲线中提取原始数据坐标,从提取的数据坐标中重建 IPD,可视化重建的 IPD,评估重建的准确性,并基于重建的 IPD 进行二次分析。我们用来自已发表研究的 K-M 曲线说明了 R 包和 Shiny 应用程序的使用。广泛的模拟和真实世界的数据应用表明,该方法在估计事件数量、风险患者数量、生存概率、中位生存时间和风险比方面具有很高的准确性和可靠性。

结论

IPDfromKM 具有很大的灵活性和准确性,可以从具有不同形状的已发表 K-M 曲线中重建 IPD。我们相信,R 包和 Shiny 应用程序将极大地方便高质量 IPD 的潜在使用,并推进二次数据的使用,以促进医疗研究中的明智决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/5adff351661d/12874_2021_1308_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/a57c79917f9e/12874_2021_1308_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/e280466998be/12874_2021_1308_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/501538aff6be/12874_2021_1308_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/2a8c326cde68/12874_2021_1308_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/01a9a9255315/12874_2021_1308_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/e9916b93d414/12874_2021_1308_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/6da9bf26a5a4/12874_2021_1308_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/7761d926c75c/12874_2021_1308_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/f6ead80b01b3/12874_2021_1308_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/e348e05f32b7/12874_2021_1308_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/cdd842b0ca06/12874_2021_1308_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/5adff351661d/12874_2021_1308_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/a57c79917f9e/12874_2021_1308_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/e280466998be/12874_2021_1308_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/501538aff6be/12874_2021_1308_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/2a8c326cde68/12874_2021_1308_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/01a9a9255315/12874_2021_1308_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/e9916b93d414/12874_2021_1308_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/6da9bf26a5a4/12874_2021_1308_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/7761d926c75c/12874_2021_1308_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/f6ead80b01b3/12874_2021_1308_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/e348e05f32b7/12874_2021_1308_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/cdd842b0ca06/12874_2021_1308_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0609/8168323/5adff351661d/12874_2021_1308_Fig12_HTML.jpg

相似文献

1
IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves.KM-IPD: 从已发表的 Kaplan-Meier 生存曲线中重建个体患者数据。
BMC Med Res Methodol. 2021 Jun 1;21(1):111. doi: 10.1186/s12874-021-01308-8.
2
IPDmada: An R Shiny tool for analyzing and visualizing individual patient data meta-analyses of diagnostic test accuracy.IPDmada:一个用于分析和可视化诊断测试准确性的个体患者数据荟萃分析的 R Shiny 工具。
Res Synth Methods. 2021 Jan;12(1):45-54. doi: 10.1002/jrsm.1444. Epub 2020 Sep 9.
3
A Method for Reconstructing Individual Patient Data From Kaplan-Meier Survival Curves That Incorporate Marked Censoring Times.一种从包含显著删失时间的Kaplan-Meier生存曲线重建个体患者数据的方法。
MDM Policy Pract. 2022 Jan 31;7(1):23814683221077643. doi: 10.1177/23814683221077643. eCollection 2022 Jan-Jun.
4
A Comparison of Statistical Analysis Between "Real" Patients Reported in Kaplan-Meier Curves and "Reconstructed" Patients Estimated Through the IPDfromKM Method: Analysis of Eight Trials Evaluating Catheter Ablation of Ventricular Tachycardia.卡普兰-迈耶曲线中报告的“真实”患者与通过IPDfromKM方法估计的“重建”患者之间的统计分析比较:八项评估室性心动过速导管消融试验的分析
Cureus. 2023 Oct 29;15(10):e47891. doi: 10.7759/cureus.47891. eCollection 2023 Oct.
5
The Reconstructed Individual Patient Data from Kaplan-Meier (IPDfromKM) Method for Non-Inferiority Analyses: A New Potential Application.用于非劣效性分析的基于Kaplan-Meier法的个体患者数据重构(IPDfromKM)方法:一种新的潜在应用
Methods Protoc. 2025 Feb 2;8(1):13. doi: 10.3390/mps8010013.
6
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses.应用KM-Shiny方法的个体参与者数据(IPD)比较针对同一疾病状况的新型治疗方法的疗效:14项分析报告
Cancers (Basel). 2023 Mar 7;15(6):1633. doi: 10.3390/cancers15061633.
7
Survival modeling for the estimation of transition probabilities in model-based economic evaluations in the absence of individual patient data: a tutorial.基于模型的经济评价中缺乏个体患者数据时的转移概率估计的生存建模:教程。
Pharmacoeconomics. 2014 Feb;32(2):101-8. doi: 10.1007/s40273-013-0123-9.
8
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group.验证加拿大癌症临床试验组进行的临床试验中从重建的 Kaplan-Meier 数据中得到的受限平均生存时间估计值与原始试验个体患者数据的一致性。
Value Health. 2022 Jul;25(7):1157-1164. doi: 10.1016/j.jval.2021.12.004. Epub 2022 Jan 29.
9
Synthetizing Published Evidence on Survival by Reconstruction of Patient-Level Data and Generation of a Multi-Trial Kaplan-Meier Curve.通过重建患者层面数据和生成多试验Kaplan-Meier曲线来综合已发表的生存证据。
Cureus. 2021 Nov 9;13(11):e19422. doi: 10.7759/cureus.19422. eCollection 2021 Nov.
10
Estimating hazard ratios from published Kaplan-Meier survival curves: A methods validation study.从发表的 Kaplan-Meier 生存曲线估计风险比:方法验证研究。
Res Synth Methods. 2019 Sep;10(3):465-475. doi: 10.1002/jrsm.1362. Epub 2019 Jun 24.

引用本文的文献

1
Treatment approaches for non-metastatic small cell bladder cancer: a meta-analysis of reconstructed Kaplan-Meier curves.非转移性小细胞膀胱癌的治疗方法:重建Kaplan-Meier曲线的荟萃分析
Clin Transl Radiat Oncol. 2025 Aug 13;55:101032. doi: 10.1016/j.ctro.2025.101032. eCollection 2025 Nov.
2
Total Intravenous Versus Inhalational Anesthesia in High-Grade Glioma Surgery: A Systematic Review and Meta-Analysis.高级别胶质瘤手术中全静脉麻醉与吸入麻醉的比较:一项系统评价与荟萃分析
Medicina (Kaunas). 2025 Aug 14;61(8):1463. doi: 10.3390/medicina61081463.
3
Implication of CDKN2A in cuproptosis through defining cuproptosis-related gene signature in ovarian cancer.

本文引用的文献

1
BOIN Suite: A Software Platform to Design and Implement Novel Early-Phase Clinical Trials.BOIN 套件:用于设计和实施新型早期临床试验的软件平台。
JCO Clin Cancer Inform. 2021 Jan;5:91-101. doi: 10.1200/CCI.20.00122.
2
Reconstructing time-to-event data from published Kaplan-Meier curves.从已发表的卡普兰-迈耶曲线重建事件发生时间数据。
Stata J. 2017 Oct;17(4):786-802.
3
A reconstructed melanoma data set for evaluating differential treatment benefit according to biomarker subgroups.一个用于根据生物标志物亚组评估差异治疗获益的重建黑色素瘤数据集。
通过定义卵巢癌中与铜死亡相关的基因特征来探讨CDKN2A在铜死亡中的作用。
J Cancer. 2025 Jul 24;16(11):3355-3371. doi: 10.7150/jca.115374. eCollection 2025.
4
Comparative efficacy of first- versus second-line CDK4/6 inhibition in hormone receptor-positive, HER2-negative metastatic breast cancer.一线与二线CDK4/6抑制在激素受体阳性、HER2阴性转移性乳腺癌中的疗效比较
Breast Cancer Res. 2025 Aug 13;27(1):146. doi: 10.1186/s13058-025-02095-6.
5
Cost-effectiveness of polatuzumab vedotin plus chemoimmunotherapy for untreated diffuse large B-cell lymphoma in China.泊洛妥珠单抗联合化疗免疫疗法治疗中国初治弥漫性大B细胞淋巴瘤的成本效益
Sci Rep. 2025 Aug 13;15(1):29752. doi: 10.1038/s41598-025-15477-9.
6
FedECA: federated external control arms for causal inference with time-to-event data in distributed settings.FedECA:用于在分布式环境中对具有事件发生时间数据进行因果推断的联邦外部对照臂。
Nat Commun. 2025 Aug 13;16(1):7496. doi: 10.1038/s41467-025-62525-z.
7
Prognostic and Predictive Value of ctDNA for Metastatic Uveal Melanoma: A Systematic Review and Meta-Analysis.循环肿瘤DNA对转移性葡萄膜黑色素瘤的预后和预测价值:一项系统评价和荟萃分析
Pigment Cell Melanoma Res. 2025 Sep;38(5):e70047. doi: 10.1111/pcmr.70047.
8
Comparative long-term outcomes of first-line CDK4/6 inhibitors plus endocrine therapy versus endocrine therapy in patients with HR+/HER2-metastatic or advanced breast cancer: a meta-analysis.一线CDK4/6抑制剂联合内分泌治疗与内分泌治疗用于HR+/HER2-转移性或晚期乳腺癌患者的比较长期结局:一项荟萃分析。
Front Pharmacol. 2025 Jul 25;16:1600892. doi: 10.3389/fphar.2025.1600892. eCollection 2025.
9
Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis.乐伐替尼联合经动脉化疗栓塞术(伴或不伴程序性死亡-1抑制剂)治疗中晚期肝细胞癌的疗效和安全性:一项系统评价和荟萃分析
Front Immunol. 2025 Jul 24;16:1586914. doi: 10.3389/fimmu.2025.1586914. eCollection 2025.
10
Total Arch Replacement with Ascyrus Medical Dissection Stent Versus Frozen Elephant Trunk in Acute Type A Aortic Dissection: A Meta-Analysis.Ascyrus医疗解剖支架全弓置换术与冰冻象鼻技术治疗急性A型主动脉夹层的Meta分析
J Clin Med. 2025 Jul 21;14(14):5170. doi: 10.3390/jcm14145170.
Data Brief. 2017 May 5;12:667-675. doi: 10.1016/j.dib.2017.05.005. eCollection 2017 Jun.
4
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.个体患者数据荟萃分析中估计受限平均生存时间差异的方法的偏倚和精度。
BMC Med Res Methodol. 2016 Mar 29;16:37. doi: 10.1186/s12874-016-0137-z.
5
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.阿特珠单抗对比多西他赛用于治疗既往接受过治疗的非小细胞肺癌患者(POPLAR):一项多中心、开放标签、2 期随机对照临床试验。
Lancet. 2016 Apr 30;387(10030):1837-46. doi: 10.1016/S0140-6736(16)00587-0. Epub 2016 Mar 10.
6
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.增强型生存数据分析:从已发表的 Kaplan-Meier 生存曲线中重建数据。
BMC Med Res Methodol. 2012 Feb 1;12:9. doi: 10.1186/1471-2288-12-9.
7
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.放疗联合西妥昔单抗治疗头颈部鳞状细胞癌。
N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422.
8
An assessment of methods to combine published survival curves.已发表生存曲线合并方法的评估
Med Decis Making. 2000 Jan-Mar;20(1):104-11. doi: 10.1177/0272989X0002000113.